Endocrine Testing Market Technological Innovations, Key Developments Players Abbott, Thermo Fisher Scientific, Beckman Coulter, Siemens Healthineers, bioMérieux

Endocrine testing involves measuring of endocrine hormone concentration in order to diagnose the various disorders such as diabetes, hypothyroidism, infertility, and other hormonal disorder. Endocrine glands secret hormones directly into bloodstream thereby helping in regulation of various body functions such as growth and development, metabolism, reproduction, stimuli response, and homeostasis. Various endocrine glands present in body include pituitary glands, thyroid glands, hypothalamus, pancreas, and adrenal glands. Any imbalance in the hormones secreted by this glands leads to certain disorder therefore they are important marker to diagnose certain condition. Endocrine testing involves testing of the hormones such as insulin, thyroid stimulating hormone, follicle stimulating hormones, human chorionic gonadotropin, progesterone, testosterone, cortisol, prolactin, and other hormones. Various assay kits are used in order to determine the concentration of hormone. It confirms presence of lower than normal or upper than normal range of hormone in blood, thereby indicating the disorder.

The global endocrine testing market was valued at US$ 2.95 billion in 2017, and is expected to witness a CAGR of 4.9% over the forecast period (2018 – 2026).

Request For Sample Copy:
https://www.coherentmarketinsights.com/insight/request-sample/1755

Global Endocrine Testing Market, By Product:
Thyroid
Insulin
Follicle Stimulating Hormone
Luteinizing Hormone
Estradiol
Testosterone
Progesterone
Human chorionic gonadotropin
Prolactin
Cortisol
DHEA-S
Others

Companies are launching innovative products to cater the end user need and increase the market footprint in the endocrine testing market. In 2017, Beckman Coulter Diagnostics received FDA clearance of its automated Access AMH immunoassay for in vitro diagnostic (IVD) use. AMH test helps healthcare providers in the assessment of a woman's ovarian reserve, thereby aid in the clinical management of women facing infertility or women planning to become pregnant later in life. The Access AMH assay is a paramagnetic particle chemiluminescent immunoassay for the quantitative determination of AMH levels. The test can be used in conjunction with other clinical and laboratory findings such as antral follicle count, before starting fertility therapy. Companies are also undergoing strategic collaboration to increase market share. For instance, in 2017, Quest diagnostics and Walmart collaborated, under which Quest would open laboratory testing services at 15 Walmart locations initially to gradually increase same.

Key companies covered as a part of this study include Abbott Laboratories, Thermo Fisher Scientific, Beckman Coulter, Inc., Siemens Healthineers, bioMérieux SA, Agilent Technologies, BioRad Laboratories, AB Sciex, F-Hoffmann La Roche AG, Quest Diagnostics, and others.

Major factor driving growth of the endocrine testing market is increasing prevalence of endocrinal disease which requires first point diagnosis. Cushing syndrome is one of major endocrinal disorder. Cushing syndrome is result of the excess exposure to hormone cortisol. Cortisol concentration may elevate due to longer treatment of chronic asthma or rheumatoid arthritis and other causes. According to American Association of Neurological Surgeon statistics, around 10-15 per million people are affected by Cushing syndrome every year. Prevalence of postmenopausal osteoporosis is high, owing to low production of estradiol in women. According to International Osteoporosis Foundation factsheet, around 30% of all postmenopausal women have osteoporosis in the US and in Europe. Among them, 40% of women suffer from one or more fragility fractures in their lifetime. Increasing ageing population is also expected to aid in growth of the endocrine testing market, owing to high prevalence of endocrinal disease. According to population Prospect report by United Nations in 2017, an estimated 962 million people are aged 60 or above in the world, which accounted for 13% of the global population. The number of older people in the world is projected to be 1.4 billion growing at annual rate of 3% by 2030.

Download the PDF brochure:
https://www.coherentmarketinsights.com/insight/request-pdf/1755

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

1001 4th Ave

This release was published on openPR.